Sun Pharma Share Price in 2009: Chart, Monthly Trends, & Analysis

How did Sun Pharma shares perform in 2009?

Let's find out!

Sun Pharma share price in 2009 was ₹136.55 Its price on 1st January 2009 was ₹95.53, and by 31st December 2009 it moved to ₹136.55, giving a positive return of 42.93% for the year.

Sun Pharma Share Open, High, Low, and Close prices for the Year 2009 are as follows:

Open	High	Low	Close
₹95.53	₹144.8	₹85.34	₹136.55
1st Jan 2009	Occured in Dec 2009	Occured in Mar 2009	31st Dec 2009

This page will help you understand how Sun Pharma performed in 2009. Let's get started.

For complete insights into Sun Pharma’s incredible stock price performance and growth, see: Sun Pharma Historical Share Price Data from its IPO to 2025

Table: Sun Pharma Share Monthly Close, Low, High Prices for 2009

Month	Sun Pharma	Change%	↑High - ↓Low
Jan	₹96.11	-	↑ ₹105.55 ↓ ₹92.16
Feb	₹91.02	-5.3%	↑ ₹100.64 ↓ ₹88.61
Mar	₹99.42	9.2%	↑ ₹100.55 ↓ ₹85.34
Apr	₹114.36	15%	↑ ₹115.31 ↓ ₹94.08
May	₹108.58	-5.1%	↑ ₹143.04 ↓ ₹106.45
Jun	₹97.56	-10.2%	↑ ₹124.61 ↓ ₹93.93
Jul	₹105.09	7.7%	↑ ₹116.74 ↓ ₹97.09
Aug	₹107.75	2.5%	↑ ₹112.71 ↓ ₹102.87
Sep	₹127.39	18.2%	↑ ₹129.78 ↓ ₹104.08
Oct	₹124.77	-2.1%	↑ ₹131.05 ↓ ₹118.47
Nov	₹131.38	5.3%	↑ ₹137.44 ↓ ₹121.81
Dec	₹136.55	3.9%	↑ ₹144.8 ↓ ₹129.41

Chart: CandleStick and Line Chart Showing Monthly Prices

[Click on line name to show/hide a line]

What if You invested ₹10,000 in Sun Pharma in 2009?

In 2009, the opening price of Sun Pharma share was ₹95.53. Today, the price stands at ₹1,676.3, reflecting a growth of 1,654.73%. If we applying the same growth to your investment of ₹10,000 then, your investment of ₹10,000 in 2009 would have become ₹1.75 Lakh by 2025. This represents a CAGR of 19.61%.

---

You might also like to check: Sun Pharma Stock Price in 2008 or Sun Pharma Stock Price in 2010

---

References: Stock prices on stockpricearchive.com are gathered from reliable sources only. We take prices from stock exchanges only, majorly from BSE and NSE.

Disclaimer: Information is provided ‘as is’ and solely for informational purposes, not for trading purposes or advice.